IP Library Granted Patent US 8,293,291
Granted Patent B2
US 8,293,291 · App. 12/213,860 · Granted Oct 23, 2012

Methods and compositions for reducing the appearance of dynamic facial wrinkles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,293,291
App. No.
12/213,860
Granted
Oct 23, 2012
Kind
B2
Abstract

The present invention relates to methods and compositions for reducing the appearance of dynamic facial wrinkles by administering oral and/or topical compositions comprising therapeutically-effective amounts of extracts of one or more relaxing herbal agents (“RHAs”) alone or in combination with one or more extracts of an edible solanaceous glycoalkaloid-containing plant (“ESGP”) or an edible glycoalkaloid-containing fungus (“EGF”) selected from plant species in the genus Solanum and mushrooms. RHAs are selected from the group consisting of extracts of Q. amara, E. angustifolia, P. oleracea, M. dubia, P. orientalis and A. muscaria and plant species from the genus Valeriana, Passiflora, Verbascum, Scutellaria, Cypripedium, Magnolia, Atriplex and Symphytum . Additionally, the methods of the present invention may comprise exfoliating the skin, preferably with at least one acid protease enzyme.

Claims (13)

1. A method for reducing the appearance of dynamic facial wrinkles in a human comprising orally administering to a human in need thereof an oral composition comprising a therapeutically-effective amount of an extract of Quassia amara and a therapeutically-effective amount of an extract of Elaeagnus angustifolia.

2. The method of claim 1 wherein the oral composition is administered at least once daily.

3. The method of claim 2 wherein the oral composition is administered at least once daily for at least two weeks.

4. The method of claim 2 wherein the oral composition is administered at a dose of at least about 25 mg/day.

5. The method of claim 1 wherein the oral composition further comprises an extract of at least one edible solanaceous glycoalkaloid-containing plant in the genus Solanum selected from the group consisting of Solanum lycopersicum, Solanum tuberosum and Solanum melongena or an edible glycoalkaloid-containing fungus selected from the group consisting of Rhizomucor miehei, Ganoderma lucidum, Lentinus edodes and Grifola frondosa.

6. The method of claim 1 further comprising an exfoliating step selected from the group consisting of

i. topical application to the area of the skin having dynamic facial wrinkles a topical composition comprising a topical exfoliating agent selected from the group consisting of alpha hydroxy acids, beta hydroxy acids, polyhydroxy acids and acid protease enzymes;

ii. microdermabrasion of the area of the skin having dynamic facial wrinkles; and

iii. topical application to the area of the skin having dynamic facial wrinkles a chemical peel.

7. The method of claim 1 wherein the oral composition further comprises a therapeutically-effective amount of at least one of adenosine or L-threonine.

8. The method of claim 1 wherein the oral composition further comprises a therapeutically-effective amount of an extract of Amanita muscaria.

9. The method of claim 5 wherein the oral composition comprises an extract of Solanum lycopersicum.

10. The method of claim 5 wherein the oral composition comprises an extract of Lentinus edodes.

Assignments (2)
CHANGE OF NAME Recorded Nov 17, 2022
From: ACTIVE ORGANICS, INC.
To: LIPOTEC USA, INC.
Reel/Frame 061810/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2017
From: SMITH, WALTER
To: ACTIVE ORGANICS, INC.
Reel/Frame 041616/0037 →